PNPLA3 I148M polymorphism is associated with elevated alanine transaminase levels in Mexican Indigenous and Mestizo populations

[1]  Nicholette D. Palmer,et al.  Characterization of european ancestry nonalcoholic fatty liver disease‐associated variants in individuals of african and hispanic descent , 2013, Hepatology.

[2]  C. Aguilar-Salinas,et al.  Association of the I148M/PNPLA3 variant with elevated alanine transaminase levels in normal-weight and overweight/obese Mexican children. , 2013, Gene.

[3]  A. Reiner,et al.  PNPLA3 gene-by-visceral adipose tissue volume interaction and the pathogenesis of fatty liver disease: The NHLBI Family Heart Study , 2012, International Journal of Obesity.

[4]  E. Boerwinkle,et al.  PNPLA3 polymorphisms and liver aminotransferase levels in a Mexican American population. , 2012, Clinical and investigative medicine. Medecine clinique et experimentale.

[5]  E. Boerwinkle,et al.  Population-based risk factors for elevated alanine aminotransferase in a South Texas Mexican-American population. , 2012, Archives of medical research.

[6]  Yang Lu,et al.  Translational genomic medicine: common metabolic traits and ancestral components of Mexican Americans , 2012, Journal of Medical Genetics.

[7]  A. Alisi,et al.  Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environment , 2012, Annals of medicine.

[8]  M. Sosa-Macías,et al.  Biochemical differences in ethnic groups in Durango, Mexico. , 2012, Ethnicity & disease.

[9]  L. Valenti,et al.  Modulation of the effect of PNPLA3 I148M mutation on steatosis and liver damage by alcohol intake in patients with chronic hepatitis C. , 2011, Journal of hepatology.

[10]  L. Perrone,et al.  The Association of PNPLA3 Variants with Liver Enzymes in Childhood Obesity Is Driven by the Interaction with Abdominal Fat , 2011, PloS one.

[11]  S. Sookoian,et al.  Meta‐analysis of the influence of I148M variant of patatin‐like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease , 2011, Hepatology.

[12]  Mei-Hwei Chang,et al.  A common variant in the PNPLA3 gene is a risk factor for non-alcoholic fatty liver disease in obese Taiwanese children. , 2011, The Journal of pediatrics.

[13]  Joel Z Stengel,et al.  Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. , 2011, Gastroenterology.

[14]  Hongyu Zhao,et al.  A common variant in the patatin‐like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents , 2010, Hepatology.

[15]  Jaimie N. Davis,et al.  Effects of PNPLA3 on Liver Fat and Metabolic Profile in Hispanic Children and Adolescents , 2010, Diabetes.

[16]  M. Mizokami,et al.  Occult hepatitis B in the genotype H‐infected Nahuas and Huichol native Mexican population , 2010, Journal of medical virology.

[17]  V. M. Cambuli,et al.  The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. , 2010, Journal of hepatology.

[18]  M. Bortolini,et al.  A functional ABCA1 gene variant is associated with low HDL-cholesterol levels and shows evidence of positive selection in Native Americans. , 2010, Human molecular genetics.

[19]  C. Day.  Genetic and Environmental Susceptibility to Non-Alcoholic Fatty Liver Disease , 2010, Digestive Diseases.

[20]  David Kershenobich,et al.  Variant in PNPLA3 is associated with alcoholic liver disease , 2010, Nature Genetics.

[21]  A. Rissanen,et al.  Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins. , 2009, Journal of hepatology.

[22]  Alexander Pertsemlidis,et al.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.

[23]  L. Morales,et al.  Risk Factors for Chronic Liver Disease in Blacks, Mexican Americans, and Whites in the United States: Results From NHANES IV, 1999–2004 , 2008, The American Journal of Gastroenterology.

[24]  D. Lawlor,et al.  Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. , 2007, Gastroenterology.

[25]  C. Aguilar-Salinas,et al.  The ATP-Binding Cassette Transporter A1 R230C Variant Affects HDL Cholesterol Levels and BMI in the Mexican Population , 2007, Diabetes.

[26]  Yoosoo Chang,et al.  Higher concentrations of alanine aminotransferase within the reference interval predict nonalcoholic fatty liver disease. , 2007, Clinical chemistry.

[27]  R. Cantor,et al.  Heritability and genetic loci of fatty liver in familial combined hyperlipidemia Published, JLR Papers in Press, September 13, 2006. , 2006, Journal of Lipid Research.

[28]  E. Boyko,et al.  The Prevalence and Predictors of Elevated Serum Aminotransferase Activity in the United States in 1999–2002 , 2006, The American Journal of Gastroenterology.

[29]  M. Manos,et al.  Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease , 2005, Hepatology.

[30]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[31]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[32]  F. Brancati,et al.  The prevalence and etiology of elevated aminotransferase levels in the United States , 2003, American Journal of Gastroenterology.

[33]  M. Kaplan,et al.  Evaluation of abnormal liver-enzyme results in asymptomatic patients. , 2000, The New England journal of medicine.

[34]  J. Ordovás,et al.  The apolipoprotein E4 allele is not associated with an abnormal lipid profile in a Native American population following its traditional lifestyle. , 1999, Atherosclerosis.

[35]  A. Scheen,et al.  Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty , 1998, International Journal of Obesity.

[36]  A. Rubio,et al.  Elevated serum liver enzymes in obesity: a dilemma during clinical trials. , 1991, International journal of obesity.

[37]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.